Paper28848352
Suppression of human arthritis synovial fibroblasts inflammation using dexamethasone-carbon nanotubes via increasing caveolin-dependent endocytosis and recovering mitochondrial membrane potential.
Lee YK and 5 others. Int J Nanomedicine, 2017. Cited by 33 papers, by iCite.
Cite this record
ConductScience Library. Suppression of human arthritis synovial fibroblasts inflammation using dexamethasone-carbon nanotubes via increasing caveolin-dependent endocytosis and recovering mitochondrial membrane potential. Papers, record 28848352. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/28848352
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Suppression of human arthritis synovial fibroblasts inflammation using dexamethasone-carbon nanotubes via increasing caveolin-dependent endocytosis and recovering mitochondrial membrane potential.
- PubMed
Topics16
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Arthritis, Rheumatoid | Major topic |
| Dexamethasone | Major topic |
| Drug Delivery Systems | Major topic |
| Fibroblasts | Major topic |
| Nanotubes, Carbon | Major topic |
| Adult | |
| Caveolins | |
| Cells, Cultured | |
| Cytokines | |
| Endocytosis | |
| Humans | |
| Inflammation | |
| Membrane Potential, Mitochondrial | |
| Middle Aged | |
| Synovial Membrane | |
| Tumor Necrosis Factor-alpha |
Source PubMed
References39
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 16233988 | Applications of carbon nanotubes in drug delivery. | Curr Opin Chem Biol | 2005 | https://conductscience.org/library/papers/16233988 | PubMed |
| 2 | 22566958 | Inflammation and bone destruction in arthritis: synergistic activity of immune and mesenchymal cells in joints. | Front Immunol | 2012 | https://conductscience.org/library/papers/22566958 | PubMed |
| 3 | 8501748 | An imaginative approach to synovitis--the role of hypoxic reperfusion damage in arthritis. | J Rheumatol Suppl | 1993 | https://conductscience.org/library/papers/8501748 | PubMed |
| 4 | 10807157 | Review: Free radicals, antioxidants, and the immune system. | Ann Clin Lab Sci | 2000 | https://conductscience.org/library/papers/10807157 | PubMed |
| 5 | 8250945 | A new method for the cytofluorimetric analysis of mitochondrial membrane potential using the J-aggregate forming lipophilic cation 5,5',6,6'-tetrachloro-1,1',3,3'-tetraethylbenzimidazolcarbocyanine iodide (JC-1). | Biochem Biophys Res Commun | 1993 | https://conductscience.org/library/papers/8250945 | PubMed |
| 6 | 539847 | Liposome-incorporated corticosteroids. II. Therapeutic activity in experimental arthritis. | Ann Rheum Dis | 1979 | https://conductscience.org/library/papers/539847 | PubMed |
| 7 | 7747120 | Hypoxia and the rheumatoid joint: immunological and therapeutic implications. | Scand J Rheumatol Suppl | 1995 | https://conductscience.org/library/papers/7747120 | PubMed |
| 8 | 15535839 | Oxidation in rheumatoid arthritis. | Arthritis Res Ther | 2004 | https://conductscience.org/library/papers/15535839 | PubMed |
| 9 | 7552073 | Hypoxia, oxidative stress and rheumatoid arthritis. | Br Med Bull | 1995 | https://conductscience.org/library/papers/7552073 | PubMed |
| 10 | 24028581 | Nullifying tumor efflux by prolonged endolysosome vesicles: development of low dose anticancer-carbon nanotube drug. | ACS Nano | 2013 | https://conductscience.org/library/papers/24028581 | PubMed |
| 11 | 23508298 | A matrix metalloproteinase 1-cleavable composite peptide derived from transforming growth factor β-inducible gene h3 potently inhibits collagen-induced arthritis. | Arthritis Rheum | 2013 | https://conductscience.org/library/papers/23508298 | PubMed |
| 12 | 18613841 | The role and therapeutic implications of fibroblast-like synoviocytes in inflammation and cartilage erosion in rheumatoid arthritis. | Immunol Rev | 2008 | https://conductscience.org/library/papers/18613841 | PubMed |
| 13 | 17867649 | Functionalized carbon nanotubes in drug design and discovery. | Acc Chem Res | 2008 | https://conductscience.org/library/papers/17867649 | PubMed |
| 14 | 17609668 | Pathways of clathrin-independent endocytosis. | Nat Rev Mol Cell Biol | 2007 | https://conductscience.org/library/papers/17609668 | PubMed |
| 15 | 19730421 | Preparation of carbon nanotube bioconjugates for biomedical applications. | Nat Protoc | 2009 | https://conductscience.org/library/papers/19730421 | PubMed |
| 16 | 14520364 | Lasker Clinical Medical Research Award. TNF defined as a therapeutic target for rheumatoid arthritis and other autoimmune diseases. | Nat Med | 2003 | https://conductscience.org/library/papers/14520364 | PubMed |
| 17 | 22991470 | Engineering of blended nanoparticle platform for delivery of mitochondria-acting therapeutics. | Proc Natl Acad Sci U S A | 2012 | https://conductscience.org/library/papers/22991470 | PubMed |
| 18 | 26791157 | TNF and ROS Crosstalk in Inflammation. | Trends Cell Biol | 2016 | https://conductscience.org/library/papers/26791157 | PubMed |
| 19 | 27057749 | Targeted delivery of low-dose dexamethasone using PCL-PEG micelles for effective treatment of rheumatoid arthritis. | J Control Release | 2016 | https://conductscience.org/library/papers/27057749 | PubMed |
| 20 | 23147896 | Duality of fibroblast-like synoviocytes in RA: passive responders and imprinted aggressors. | Nat Rev Rheumatol | 2013 | https://conductscience.org/library/papers/23147896 | PubMed |
Cited by21
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 33 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42471867 | Signal-driven interplay between lipid peroxidation and ferroptosis orchestrates osteoarthritis degeneration. | J Orthop Translat | 2026 | https://conductscience.org/library/papers/42471867 | PubMed |
| 42330243 | In Vitro Cytotoxicity and Inflammatory Response of Local Anaesthetics and Corticosteroids in Canine Fibroblast-Like Synoviocytes. | Cartilage | 2026 | https://conductscience.org/library/papers/42330243 | PubMed |
| 40778471 | Revolutionizing Autoimmune Research: The Role of Caveolin-1. | Immun Inflamm Dis | 2025 | https://conductscience.org/library/papers/40778471 | PubMed |
| 40343168 | Nanodrug delivery systems targeting ferroptosis as an innovative therapeutic approach for Rheumatoid Arthritis. | Mater Today Bio | 2025 | https://conductscience.org/library/papers/40343168 | PubMed |
| 39381557 | Apurinic/apyrimidinic endonuclease 1 alleviates inflammation in fibroblast-like synoviocytes from patients with rheumatoid arthritis. | Cent Eur J Immunol | 2024 | https://conductscience.org/library/papers/39381557 | PubMed |
| 38607179 | Supramolecular Hydrogel Dexamethasone-Diclofenac for the Treatment of Rheumatoid Arthritis. | Nanomaterials (Basel) | 2024 | https://conductscience.org/library/papers/38607179 | PubMed |
| 38130933 | Particulate matter 10 induces oxidative stress and apoptosis in rhesus macaques skin fibroblast. | PeerJ | 2023 | https://conductscience.org/library/papers/38130933 | PubMed |
| 37518822 | Arthritic Microenvironment-Dictated Fate Decisions for Stem Cells in Cartilage Repair. | Adv Sci (Weinh) | 2023 | https://conductscience.org/library/papers/37518822 | PubMed |
| 35547865 | Knee Osteoarthritis Therapy: Recent Advances in Intra-Articular Drug Delivery Systems. | Drug Des Devel Ther | 2022 | https://conductscience.org/library/papers/35547865 | PubMed |
| 35335310 | Modification of Lipid-Based Nanoparticles: An Efficient Delivery System for Nucleic Acid-Based Immunotherapy. | Molecules | 2022 | https://conductscience.org/library/papers/35335310 | PubMed |
| 34776567 | PEGylated green halloysite/spinel ferrite nanocomposites for pH sensitive delivery of dexamethasone: A potential pulmonary drug delivery treatment option for COVID-19. | Appl Clay Sci | 2022 | https://conductscience.org/library/papers/34776567 | PubMed |
| 34518771 | Endocytosis of abiotic nanomaterials and nanobiovectors: Inhibition of membrane trafficking. | Nano Today | 2021 | https://conductscience.org/library/papers/34518771 | PubMed |
| 34515606 | Targeted treatment for osteoarthritis: drugs and delivery system. | Drug Deliv | 2021 | https://conductscience.org/library/papers/34515606 | PubMed |
| 34326636 | Structural Deformation of MTX Induced by Nanodrug Conjugation Dictate Intracellular Drug Transport and Drug Efficacy. | Int J Nanomedicine | 2021 | https://conductscience.org/library/papers/34326636 | PubMed |
| 34299030 | Internalization of Neutrophil-Derived Microvesicles Modulates TNFα-Stimulated Proinflammatory Cytokine Production in Human Fibroblast-Like Synoviocytes. | Int J Mol Sci | 2021 | https://conductscience.org/library/papers/34299030 | PubMed |
| 33664241 | Catalytic activity tunable ceria nanoparticles prevent chemotherapy-induced acute kidney injury without interference with chemotherapeutics. | Nat Commun | 2021 | https://conductscience.org/library/papers/33664241 | PubMed |
| 32784839 | Therapeutic Manipulation of Macrophages Using Nanotechnological Approaches for the Treatment of Osteoarthritis. | Nanomaterials (Basel) | 2020 | https://conductscience.org/library/papers/32784839 | PubMed |
| 32722403 | Polymer Nanomedicines with Ph-Sensitive Release of Dexamethasone for the Localized Treatment of Inflammation. | Pharmaceutics | 2020 | https://conductscience.org/library/papers/32722403 | PubMed |
| 30862551 | Intra-articular targeting of nanomaterials for the treatment of osteoarthritis. | Acta Biomater | 2019 | https://conductscience.org/library/papers/30862551 | PubMed |
| 30343452 | Intraarticular injection of dexamethasone promotes bone erosion in collagen-induced arthritis in mice through up-regulation of RANKL expression. | Inflammopharmacology | 2019 | https://conductscience.org/library/papers/30343452 | PubMed |
Genes9
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| EEA1 | 8411 | PubTator's text mining | https://conductscience.org/library/genes/8411 | NCBI Gene |
| GAPDH | 2597 | PubTator's text mining | https://conductscience.org/library/genes/2597 | NCBI Gene |
| IL1B | 3553 | PubTator's text mining | https://conductscience.org/library/genes/3553 | NCBI Gene |
| IL6 | 3569 | PubTator's text mining | https://conductscience.org/library/genes/3569 | NCBI Gene |
| LYZ | 4069 | PubTator's text mining | https://conductscience.org/library/genes/4069 | NCBI Gene |
| MMP1 | 4312 | PubTator's text mining | https://conductscience.org/library/genes/4312 | NCBI Gene |
| MMP3 | 4314 | PubTator's text mining | https://conductscience.org/library/genes/4314 | NCBI Gene |
| POTEF | 728378 | PubTator's text mining | https://conductscience.org/library/genes/728378 | NCBI Gene |
| TNF | 7124 | PubTator's text mining | https://conductscience.org/library/genes/7124 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/28848352
GET https://conductscience.org/api/papers/v1/28848352/references?page=2